e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)
C. Gunduz (Izmir, Turkey)
Source:
International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Session:
Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Session type:
Oral Presentation
Number:
3208
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gunduz (Izmir, Turkey). Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA). 3208
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
The sleepy phenotype in mild Obstructive Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA).
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021
Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018
Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA)
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021
Obstructive Sleep Apnea (OSA) Assessment in the elderly. Preliminary results.
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
Source: Eur Respir J 2011; 38: 635-642
Year: 2011
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Source: Sleep and Breathing Conference 2021
Year: 2021
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
Source: Eur Respir J, 55 (6) 2001323; 10.1183/13993003.01323-2020
Year: 2020
Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study
Source: International Congress 2017 – What is new in respiratory and sleep physiology?
Year: 2017
Asthma and Obstructive Sleep Apnea Syndrome (OSAS)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Hyperlipidemia Prevalence and Cholesterol Control in OSA: Data from European Sleep Apnea Database (ESADA)
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019
Obstructive sleep apnoea is associated with the increased prothrombotic state
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014
Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA)
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
Smoking status, clinical presentation and outcomes in obstructive sleep apnoea
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Prevalence of obstructive sleep apnea (OSA) in patients with lung cancer. Results from the prospective SAIL study Sleep Apnea In Lung Cancer)
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept